期刊文献+

特发性炎性肌病骨骼肌炎症浸润的组织病理学分析 被引量:2

Histologic Analysis of Inflammatory Infiltration in Skeletal Muscle of Idiopathic Inflammatory Myopathy
下载PDF
导出
摘要 目的:研究多发性肌炎(PM)和皮肌炎(DM)患者骨骼肌组织中浸润的炎性细胞的类型、分布和定位,探讨它们在特发性炎性肌病(IIM)发病机制中的作用。方法:选取IIM患者肌肉组织标本45例,其中PM19例,DM26例。用免疫组织化学方法检测PM/DM患者骨骼肌组织中CD3、CD4、CD8、CD20、CD45RA和CD45RO分子的表达。结果:PM组肌组织的损伤主要表现为肌纤维坏死和肌内膜炎,而DM组主要表现为束周萎缩和血管周围炎。CD3、CD8和CD45RO分子在PM和DM患者肌组织中均有阳性表达,两组间表达量差异无统计学意义(P均>0.05),主要分布在PM/DM患者肌组织的肌内膜和血管周围处。而CD20、CD4、CD45RA分子在DM组的阳性表达量较PM组明显增多(P均<0.05),且主要分布在血管周围。结论:细胞免疫和体液免疫均参与了PM和DM的发病,而体液免疫在DM的发病中可能起更主要的作用。 Objective:To characterize the inflammatory cells and analyze the cellular distribution in skeletal muscle of idiopathic inflammatory myopathies (IIM), and study their pathogenetic roles in IIM. Methods: Forty-five muscular biopsy specimens of patients with IIM (19 polymyositis and 26 dermatomyositis) were selected in study. Immunohistochemical staining was applied to detect expressions of CD3, CD4, CD8, CD20, CD45RA and CD45RO on PM/DM patients. Results:The major pathologic features in patients with PM were necrosis of muscular fibers and inflammatory infiltration on endomysium, while the characteristics in patients with DM were perifascicular atrophy and perivasculitis. The positive expression of CD3^+ , CD8^+ , CD45RO^+ T lymphocytes were similar in PM and DM (P〉0. 05), and they were more frequently found at the perivascular and endomysial regions in both groups. CD4^+, CD20^+, CD45RA^+ T lymphocytes expressed more marked in DM group than those in PM group (P〈0. 05), and mainly distributed at the perivascular regions. Conclusion: Both cellular and humoral immunity involved in the development of PM and DM, but humoral immunity play a more important role in DM.
出处 《内科急危重症杂志》 2008年第3期142-145,共4页 Journal of Critical Care In Internal Medicine
基金 国家自然科学基金资助项目(No:30170885) 北京中日友好医院重点学科资助项目
关键词 特发性炎性肌病 炎性细胞 Idiopathic inflammatory myopathy Inflammatory cells
  • 相关文献

参考文献10

  • 1Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet, 2003, 362:971.
  • 2Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 1975, 292:344.
  • 3Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med, 1975, 292:403.
  • 4Nagaraju K, Raben N, Loeffler L, et al. Conditional up-regulation of MHC class Ⅰ in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA, 2000, 97:9209.
  • 5Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest, 1996, 97:2905.
  • 6Basta M, Dalakas MC, High dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest, 1994, 94:1729.
  • 7Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol, 1990, 27:343.
  • 8Vianna MA, Borges C, Eduardo FE, et al. Myositis in mixed connective tissue disease. A unique syndrome characterized by immunohistopathologic elements of both polymyositis and dermatomyositis. Arq Neuropsiquiatr, 2004, 62:923.
  • 9Clement LT. Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation. J Clin Immunol, 1992, 12:1.
  • 10De Bleecker JL, Engel AG. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies, Am J Pathol, 1995, 146:1178.

同被引文献23

  • 1刘继峰,许爱娥,宋芳吉.多发性肌炎/皮肌炎患者外周血单个核细胞中糖皮质激素受体α、β mRNA表达与糖皮质激素疗效相关性的研究[J].中国免疫学杂志,2007,23(4):364-367. 被引量:13
  • 2Takizawa Y,Kanda H,Sato K,et al. Polymyositis associated with focal mesangial proliferative glomerulonephritis with depositions of immune complexes[J]. Clin Rheumatol,2007,26(5) :792 -796.
  • 3Vianna MA, Borges C, Eduardo FE,et al. Myositis in mixed connective tissue disease. A unique syndrom characterized by immunohistopathologic elements of both polymyositis and dermatomyositis[J]. Arq Neuropsiquiatr, 2004,62 : 923.
  • 4Cerda Tellez F, Irozoque Palazuelos F, Andrade Ortega,et al. intravenous immunoglobulin treatment in patients with idiopathic inflammatory myopathics[J]. Rheumatology, 2006,12: S15.
  • 5Danieli MG,Calcabrini I.,Marchetti A,et al. Intr avenous immunoglobulin treatment in autoimmune patients[J]. Recenti Prog Med,2007,98:322- 326.
  • 6Anandacoo marasamy A, Howe G Manolios N. Advanced refractory polymyositis responding to infliximab [J]. Rheumatology (Oxford),2005,44:562- 563.
  • 7Labioche I, Liozon E, Weschler B, et al. Refractory polymyositis responding to infliximab:extended follow up[J]. Rheumatology (Oxford), 2004,43 :531-532.
  • 8Marie I, Heliot P, Roussel F, et al. Fatal Mycohaeterium peregrihum pneumonia inrefractory polymyositis treated with infliximab [J]. Rheumatology(Oxford), 2005,44:1201-1202.
  • 9Wendling D,Prati C, Ometti P, et al. Anti TNF alpha treatment of a refractory polymyositis[J]. Rev Med Interne,2007,28:194- 195.
  • 10Hengstman GJ,DeBleekcr JL, Feist E,et al. Open label trial of anti TNF-a in dermatomyositis and polymyositis treated concomitantly with methotrexate[J]. Eur Neurol,2008,59: 159-163.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部